Biotech Values

[jq1234]

By contrast, a third group of patients who got Avonex, an older injected treatment from Biogen Idec Inc. (BIIB), had fewer relapses than those who got a placebo in the study.

“Laquinimod is dead, if not regulatorily, then commercially,” said Ori Hershkovitz, a partner at Sphera Funds Management Ltd. in Tel Aviv.

http://www.bloomberg.com/news/2011-08-01/teva-s-oral-multiple-sclerosis-drug-fails-to-meet-goal-of-clinical-trial.html